idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresiva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
lorista 100mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 14167 draselnÁ sŮl losartanu - potahovaná tableta - 100mg - losartan
lorista 12,5mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 14167 draselnÁ sŮl losartanu - potahovaná tableta - 12,5mg - losartan
lorista 25mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 14167 draselnÁ sŮl losartanu - potahovaná tableta - 25mg - losartan
lorista 50mg potahovaná tableta
krka, d.d., novo mesto, novo mesto array - 14167 draselnÁ sŮl losartanu - potahovaná tableta - 50mg - losartan